Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N V Acharya

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Safety|March 10, 2001
Incompleteness of lamotrigine dataN V Acharya, L V Wilton, S A Shakir
European Journal of Clinical Pharmacology|September 11, 2001
Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997P M Craig-McFeely, N V Acharya, S A Shakir
International Journal of Clinical Pharmacology and Therapeutics|February 12, 2005
Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim reportN V Acharya, L V Wilton, S A W Shakir
International Journal of Obesity (2005)|March 23, 2006
Safety profile of orlistat: results of a prescription-event monitoring studyN V Acharya, L V Wilton, S A W Shakir
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Safety|March 10, 2001
Incompleteness of lamotrigine dataN V Acharya, L V Wilton, S A Shakir
European Journal of Clinical Pharmacology|September 11, 2001
Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997P M Craig-McFeely, N V Acharya, S A Shakir
International Journal of Clinical Pharmacology and Therapeutics|February 12, 2005
Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim reportN V Acharya, L V Wilton, S A W Shakir
International Journal of Obesity (2005)|March 23, 2006
Safety profile of orlistat: results of a prescription-event monitoring studyN V Acharya, L V Wilton, S A W Shakir
Pageof 1